{
    "2018-10-03": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Top 5 Biotech Stocks for 2018",
                "features": {
                    "keywords": [
                        "biotech",
                        "stocks",
                        "2018"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Gilead, HiFiBiO Collaborate to Develop T-Cell Receptors",
                "features": {
                    "keywords": [
                        "Gilead",
                        "HiFiBiO",
                        "T-Cell",
                        "Receptors"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Cramer's lightning round: The sweet spot for buying shares of Clorox",
                "features": {
                    "keywords": [
                        "Cramer",
                        "Clorox",
                        "buying",
                        "shares"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Noteworthy Wednesday Option Activity: FIT, ROST, ABBV",
                "features": {
                    "keywords": [
                        "option activity",
                        "FIT",
                        "ROST",
                        "ABBV"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Here's Why J&J (JNJ) is a Good Bet in a Troubled Market",
                "features": {
                    "keywords": [
                        "JNJ",
                        "troubled market",
                        "good bet"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Why AbbVie (ABBV) is Poised to Beat Earnings Estimates Again",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "earnings estimates",
                        "poised"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "Merck & Other Pharma Players Await FDA Decisions in October",
                "features": {
                    "keywords": [
                        "Merck",
                        "FDA",
                        "decisions",
                        "pharma"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Here's Why J&J (JNJ) is a Good Bet in a Troubled Market",
                "features": {
                    "keywords": [
                        "JNJ",
                        "troubled market",
                        "good bet"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Mylanâ€™s Humira Biosimilar Opportunity in Europe",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Humira",
                        "biosimilar",
                        "Europe"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "The hidden dangers of testosterone replacement therapy you should know about",
                "features": {
                    "keywords": [
                        "testosterone",
                        "replacement",
                        "therapy",
                        "dangers"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-13",
                "original_text": "Nobel Recognizes Science Leading to AbbVie's Top-Selling Drug",
                "features": {
                    "keywords": [
                        "Nobel",
                        "science",
                        "AbbVie",
                        "top-selling drug"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}